Structure of PDB 1s63 Chain A |
>1s63A (length=315) Species: 9606 (Homo sapiens) [Search protein sequence] |
FVSLDSPSYVLYRDRAEWADIDPVPQNDGPNPVVQIIYSDKFRDVYDYFR AVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLKSLQKDLHEEMNY ITAIIEEQPKNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQ HRQWVIQEFKLWDNELQYVDQLLKEDVRNNSVWNQRYFVISNTTGYNDRA VLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSKYPNLLNQLLDLQP SHSSPYLIAFLVDIYEDMLENQCDNKEDILNKALELCEILAKEKDTIRKE YWRYIGRSLQSKHST |
|
PDB | 1s63 Crystallographic Analysis Reveals that Anticancer Clinical Candidate L-778,123 Inhibits Protein Farnesyltransferase and Geranylgeranyltransferase-I by Different Binding Modes. |
Chain | A |
Resolution | 1.9 Å |
3D structure |
|
|
Catalytic site (original residue number in PDB) |
K164 |
Catalytic site (residue number reindexed from 1) |
K110 |
Enzyme Commision number |
2.5.1.58: protein farnesyltransferase. 2.5.1.59: protein geranylgeranyltransferase type I. |
|
|
|
|